KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Shares Issued (2018 - 2025)

Adaptive Biotechnologies (ADPT) has disclosed Shares Issued for 8 consecutive years, with $3.8 million as the latest value for Q4 2025.

  • Quarterly Shares Issued rose 2875.59% to $3.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.5 million through Dec 2025, up 5096.68% year-over-year, with the annual reading at $12.5 million for FY2025, 5096.68% up from the prior year.
  • Shares Issued hit $3.8 million in Q4 2025 for Adaptive Biotechnologies, up from $1.7 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $26.3 million in Q4 2021 to a low of $17000.0 in Q3 2023.
  • Historically, Shares Issued has averaged $2.8 million across 5 years, with a median of $750500.0 in 2022.
  • Biggest five-year swings in Shares Issued: crashed 98.78% in 2022 and later soared 12288.64% in 2025.
  • Year by year, Shares Issued stood at $26.3 million in 2021, then plummeted by 98.78% to $322000.0 in 2022, then plummeted by 72.98% to $87000.0 in 2023, then surged by 45.98% to $127000.0 in 2024, then skyrocketed by 2875.59% to $3.8 million in 2025.
  • Business Quant data shows Shares Issued for ADPT at $3.8 million in Q4 2025, $1.7 million in Q3 2025, and $1.6 million in Q2 2025.